SCHEMBL10501980

SCHEMBL10501980

COc1ccc2[se]n(-c3ccccn3)c(=S)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 2/20 0.41
▸ TXNRD1 Q16881 1/20 0.40
▸ TXNRD3 Q86VQ6 1/20 0.40
▸ TXNRD2 Q9NNW7 1/20 0.40
▸ SLC11A2 P49281 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MAPT P10636 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ PDCD1 Q15116 1/20 0.37
▸ CD274 Q9NZQ7 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ HTR1A P08908 2/20 0.35
▸ ADRA1D P25100 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ ADRA1B P35368 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10502051 0.91 SLC11A2 (0.40) METAP2SLC11A2ALDH1A1KDM4EL3MBTL1
SCHEMBL10746448 0.85 TXNRD1 (0.43) METAP2TXNRD1TXNRD3TXNRD2ALDH1A1
SCHEMBL10501793 0.85 TXNRD1 (0.52) METAP2TXNRD1TXNRD3TXNRD2SLC11A2
SCHEMBL10501631 0.80 MAT2A (0.38) METAP2ALDH1A1KDM4ELMNAMAPT
SCHEMBL10503543 0.80 METAP2 (0.50) METAP2TXNRD1TXNRD3TXNRD2ALDH1A1
SCHEMBL11020733 0.79 METAP2 (0.38) METAP2TXNRD1TXNRD3TXNRD2ALDH1A1
SCHEMBL10502474 0.79 ALDH1A1 (0.38) METAP2ALDH1A1KDM4ELMNAMAPT
SCHEMBL5916746 0.78 METAP2 (0.53) METAP2TXNRD1TXNRD3TXNRD2SLC11A2
SCHEMBL10748075 0.77 MAPT (0.40) METAP2ALDH1A1KDM4EMAPT
SCHEMBL10501833 0.76 NPC1 (0.43) METAP2TXNRD1TXNRD3TXNRD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback